These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29119928)

  • 1. Rational Basis for Nutraceuticals in the Treatment of Glaucoma.
    Morrone LA; Rombola L; Adornetto A; Corasaniti MT; Russo R
    Curr Neuropharmacol; 2018; 16(7):1004-1017. PubMed ID: 29119928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2013 Feb; 2(2):CD006539. PubMed ID: 23450569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of nutraceuticals on glaucoma: A systematic review.
    Scuteri D; Rombolà L; Watanabe C; Sakurada S; Corasaniti MT; Bagetta G; Tonin P; Russo R; Nucci C; Morrone LA
    Prog Brain Res; 2020; 257():141-154. PubMed ID: 32988469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant nutraceuticals for glaucoma].
    Karpilova MA; Poluianova AD
    Vestn Oftalmol; 2020; 136(4. Vyp. 2):317-323. PubMed ID: 32880157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.
    Vernazza S; Oddone F; Tirendi S; Bassi AM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
    Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
    J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma.
    Cammalleri M; Dal Monte M; Amato R; Bagnoli P; Rusciano D
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32340314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspective of neuroprotection and glaucoma.
    Tian K; Shibata-Germanos S; Pahlitzsch M; Cordeiro MF
    Clin Ophthalmol; 2015; 9():2109-18. PubMed ID: 26635467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy.
    Jiang S; Kametani M; Chen DF
    Front Immunol; 2020; 11():65. PubMed ID: 32117239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural compounds and retinal ganglion cell neuroprotection.
    Morrone LA; Rombolà L; Corasaniti MT; Bagetta G; Nucci C; Russo R
    Prog Brain Res; 2015; 220():257-81. PubMed ID: 26497795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
    Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of potential novel glaucoma therapeutic options independent of intraocular pressure.
    Shalaby WS; Ahmed OM; Waisbourd M; Katz LJ
    Surv Ophthalmol; 2022; 67(4):1062-1080. PubMed ID: 34890600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective therapies for glaucoma.
    Song W; Huang P; Zhang C
    Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
    Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
    J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma.
    Nitta E; Hirooka K; Tenkumo K; Fujita T; Nishiyama A; Nakamura T; Itano T; Shiraga F
    Cell Death Dis; 2013 Jul; 4(7):e711. PubMed ID: 23828574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary modification and antioxidant supplementation on intraocular pressure and open-angle glaucoma.
    Jabbehdari S; Chen JL; Vajaranant TS
    Eur J Ophthalmol; 2021 Jul; 31(4):1588-1605. PubMed ID: 33008269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.